205 related articles for article (PubMed ID: 24485401)
1. The extrinsic coagulation cascade and tissue factor pathway inhibitor in macrophages: a potential therapeutic opportunity for atherosclerotic thrombosis.
Jiang P; Xue D; Zhang Y; Ye L; Liu Y; Makale M; Kesari S; Edgington TS; Liu C
Thromb Res; 2014 Apr; 133(4):657-66. PubMed ID: 24485401
[TBL] [Abstract][Full Text] [Related]
2. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor and atherothrombosis.
Saha D; S S; Sergeeva EG; Ionova ZI; Gorbach AV
Curr Pharm Des; 2015; 21(9):1152-7. PubMed ID: 25312727
[TBL] [Abstract][Full Text] [Related]
4. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.
Kaikita K; Takeya M; Ogawa H; Suefuji H; Yasue H; Takahashi K
J Pathol; 1999 Jun; 188(2):180-8. PubMed ID: 10398162
[TBL] [Abstract][Full Text] [Related]
5. Dyslipidemia shifts the tissue factor/tissue factor pathway inhibitor balance toward increased thrombogenicity in atherosclerotic plaques: evidence for a corrective effect of statins.
Zawadzki C; Susen S; Richard F; Haulon S; Corseaux D; Jeanpierre E; Vincentelli A; Lucas C; Torpier G; Martin A; Van Belle E; Staels B; Jude B
Atherosclerosis; 2007 Dec; 195(2):e117-25. PubMed ID: 17196206
[TBL] [Abstract][Full Text] [Related]
6. Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis.
Hutter R; Valdiviezo C; Sauter BV; Savontaus M; Chereshnev I; Carrick FE; Bauriedel G; Lüderitz B; Fallon JT; Fuster V; Badimon JJ
Circulation; 2004 Apr; 109(16):2001-8. PubMed ID: 15078795
[TBL] [Abstract][Full Text] [Related]
7. Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques.
van Montfoort ML; Kuijpers MJ; Knaup VL; Bhanot S; Monia BP; Roelofs JJ; Heemskerk JW; Meijers JC
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1668-73. PubMed ID: 24947525
[TBL] [Abstract][Full Text] [Related]
8. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.
Mackman N; Tilley RE; Key NS
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1687-93. PubMed ID: 17556654
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor in atherosclerosis and atherothrombosis.
Grover SP; Mackman N
Atherosclerosis; 2020 Aug; 307():80-86. PubMed ID: 32674807
[TBL] [Abstract][Full Text] [Related]
10. The effect of vascular smooth muscle cell-targeted expression of tissue factor pathway inhibitor in a murine model of arterial thrombosis.
Pan S; Kleppe LS; Witt TA; Mueske CS; Simari RD
Thromb Haemost; 2004 Sep; 92(3):495-502. PubMed ID: 15351845
[TBL] [Abstract][Full Text] [Related]
11. Vascular wall hypoxia promotes arterial thrombus formation via augmentation of vascular thrombogenicity.
Matsuura Y; Yamashita A; Iwakiri T; Sugita C; Okuyama N; Kitamura K; Asada Y
Thromb Haemost; 2015 Jul; 114(1):158-72. PubMed ID: 25833755
[TBL] [Abstract][Full Text] [Related]
12. Relevance of tissue factor in cardiovascular disease.
Jude B; Zawadzki C; Susen S; Corseaux D
Arch Mal Coeur Vaiss; 2005 Jun; 98(6):667-71. PubMed ID: 16007822
[TBL] [Abstract][Full Text] [Related]
13. Regulation of tissue factor--mediated initiation of the coagulation cascade by cell surface grp78.
Bhattacharjee G; Ahamed J; Pedersen B; El-Sheikh A; Mackman N; Ruf W; Liu C; Edgington TS
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1737-43. PubMed ID: 15947236
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice.
Westrick RJ; Bodary PF; Xu Z; Shen YC; Broze GJ; Eitzman DT
Circulation; 2001 Jun; 103(25):3044-6. PubMed ID: 11425765
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor pathway inhibitor expression in atherosclerosis.
Drew AF; Davenport P; Apostolopoulos J; Tipping PG
Lab Invest; 1997 Oct; 77(4):291-8. PubMed ID: 9354763
[TBL] [Abstract][Full Text] [Related]
16. Low thrombogenicity of calcified atherosclerotic plaques is associated with bone morphogenetic protein-2-dependent inhibition of tissue factor expression.
Egorina EM; Sovershaev MA; Bogdanov VY; Sovershaev TA; Fallon JT; Seredkina N; Østerud B; Hansen JB
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):642-50. PubMed ID: 21897206
[TBL] [Abstract][Full Text] [Related]
17. Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells.
Breitenstein A; Stein S; Holy EW; Camici GG; Lohmann C; Akhmedov A; Spescha R; Elliott PJ; Westphal CH; Matter CM; Lüscher TF; Tanner FC
Cardiovasc Res; 2011 Feb; 89(2):464-72. PubMed ID: 20978007
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages : relationship to tissue factor induction by cholesterol and oxidized LDL.
Petit L; Lesnik P; Dachet C; Moreau M; Chapman MJ
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):309-15. PubMed ID: 9974412
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
[TBL] [Abstract][Full Text] [Related]
20. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
